The Life Science Rundown cover art

All Episodes

The Life Science Rundown — 81 episodes

#
Title
1

Managing AI Risk Across Global Quality Systems

2

The Case for Engaging Regulatory Early

3

Why Quality and R&D Default to Conflict (and How to Fix It)

4

Leading Through the AI Shift with ASQ's CEO Sid Bhatnagar

5

Why Your CAPA System Isn't Driving Improvement (and How to Fix It)

6

TerSera's VP of Quality on the Audit Risk Hiding Inside Your Own Procedures

7

What Auditors Are Actually Looking For — and the Psychology Behind How They Find It

8

Why Kidney Disease Innovation Is a Tale of Two Cities — and What It Would Take to Change That

9

Syncing Global Regulatory Filings Across FDA, EMA, and PMDA with AJ Acker

10

Navigating Regulatory Leadership Across Large and Small Life Science with Tammy Sarnelli

11

Getting Data Governance for Regulatory Submissions Right Before AI Gets it Wrong with Cary Smithson

12

Building Resilient Biotech Teams in Cell and Gene Therapy with Nelly Viseux

13

Building Phase-Appropriate Quality from Preclinical to Commercial with Jackie Klecker

14

Preparing the Workforce That Will Shape Pharma’s Future with ISPE President & CEO Mike Martin

15

How to Build (and Sustain) a Quality-Centric Culture with Chris Masterson

16

From Molecule to Market: A Commercial-Readiness Playbook for Biotechs with Carlos Carrillo

17

How Regulators Are Bringing AI Into Review (Without Losing Trust) with Maria Vassileva

18

A Playbook for FDA Inspections and Remediation with Jeff Hines

19

Leading Cross-Functional Teams from Concept to Commercialization with Marwan Fathallah

20

Breaking Down FDA’s E21 Draft Guidance: Including Pregnant and Breastfeeding Women in Clinical Trials with Regina Atim

21

Staying Ready for the FDA (When Inspections Are Less Predictable)

22

Building the Next-Gen Lab: AI in a GLP Environment with Catherine Lunardi

23

How to Build High-Performing Quality Teams with Marcus Gesner

24

The 4 Cs of MedTech Leadership with Sean Gallimore

25

The Power (and Pitfalls) of Real-World Evidence with Dr. Manfred Stapff

26

Quality Is Not a Cost Center—It’s a Culture (with Dr. Kimberly Garko)

27

From Cost Center to Value Driver: Rethinking Quality in the Life Sciences with Marcia Baroni

28

Managing Royalties in Biotech, Pharma, and Medtech with David Marlin

29

GMP Compliance in 503B Compounding Pharmacies with Jesse Gillikan

30

A Smarter Approach to Supplier Quality Audits with Thermo Fisher's David Festa

31

Mastering FDA and EMA Regulatory Meetings with Ashley Preston

32

Working with Chinese CROs: Benefits, Risks, and Best Practices with Harri Järveläinen

33

The Smart Way to Adopt AI in Clinical Trials and Regulatory Affairs with Keith Parent

34

Demystifying AI in Life Sciences Supply Chain with Jennifer Chew

35

Streamlining Promotional Reviews in the Life Sciences with Annalise Ludtke

36

Navigating Supplier Audits in Japan with Derek Wessman

37

Small Lots, Big Risks: Rethinking Statistical Sampling in Biopharma

38

Quality Metrics that Matter with Kimberly Wallbank

39

Applying AI in the Life Sciences with MasterControl's Matt Lowe

40

Navigating Challenges in Raw Material and Finished Product Storage with Eric Busenburg

41

Building and Leading Effective Quality Assurance Teams with Aaron Snyder

42

The Pharma Startup Playbook: Advice from the Field with Taggart McGurrin

43

Navigating FDA Regulations for SaMD AI and Machine Learning with Adam Foresman

44

Crafting Quality Systems for Each Phase of Drug Development with Carlos Yuraszeck

45

Leading Through Transition: Strategic Insights from Novartis's Front Lines

46

Real Talk on Remote Leadership with Nick Klingensmith

47

Audit and FDA Inspection Readiness Best Practices with Divya Gowdar

48

Mastering the TMF: Ensuring GCP Compliance and Inspection Readiness with Donna Dorozinsky

49

The Startup's Guide to Setting Up Cell Therapy Manufacturing: Navigating Regulations, Resources and Timelines

50

A Blueprint for Quality Culture with Vincent Cafiso

51

An FDA Inspection Survival Guide with Jonathan Wacks

52

Clinical Data Standards in Focus: SDTM Compliance with Sunil Gupta

53

The Link Between Quality Culture and QA Communication Pathways with David Marks

54

Mastering Medical Device Supplier Management with Paul Hakamaki

55

Recent FDA Enforcement Trends with George Toscano

56

Growing Your Career in RA/QA with Jessica Smith Beaver, PhD

57

Drug Delivery System Innovation and Leadership with Steve Knowles

58

Motivating Technical Teams in the Life Sciences: A Conversation with Rick Beatty

59

Cross-Cultural Pharma: Mike Martin's Experiences from Puerto Rico to China

60

Courageous Leadership to Reinvent Our Healthcare System

61

The Critical Role of 'Hyper-Targeting' in Rare Disease Drug Development

62

A Journey into Life Sciences Investment: Strategies, Challenges, and Opportunities with Sal Buscemi

63

Navigating Risk Management in Medical Devices with Brian Dense

64

The DEA, FDA & Controlled Substances: An Insider's Perspective with Former DEA Agent Dennis Wichern

65

A Deep Dive into Medical Device Regulatory Strategy with Regulatory Attorney Christine P. Bump

66

Lessons from a Medtech Entrepreneur: Ram Konduru on Fostering Teamwork and Personal Growth in Leadership

67

Unlocking Effective Leadership: A Conversation with MetaComet Systems President, David Marlin

68

Leadership, Management, and Enhancing Quality of Life: A Conversation with Dan Barker, CEO of Wikimotive

69

Navigating the 510(k) Process: A Q&A with Regulatory Consultant, Trey Thorsen, MS, RAC

70

The Future of Life Science Talent Acquisition: Securing In-Demand Skills in a Competitive Market

71

FDA Revives Its Proposed Quality Metrics Program for Pharma

72

Inspection Alternatives Are Driving More FDA Enforcement Actions: What It Means for Industry

73

FDA's Domestic Biopharma Inspections Return to Normal

74

Quality Management Review: Benchmarking Quantitatively!

75

Addressing FDA's Inspection Backlog with Mary Denigan-Macauley, GAO's Director of Health Care

76

FDA's Fraudulent Products Task Force and Operation Quack Hack Battle COVID Vaccine Scams

77

What to Expect for the FDA's Regulation of Medical Devices & Digital Health Under the Biden Administration

78

Clinical Outsourcing & Insourcing: Selecting the Right Model or Mix

79

What RA/QA/Clinical Leaders Should Expect From the FDA in 2021

80

Inside FDA Pre-Approval Inspections with Former FDA Investigator, Christopher Smith

81

A Look at FDA's Pandemic Inspections Q&A Guidance